Idexx Laboratories | IDXX - Operating Expenses

Stock Price
634.92
Daily Change
11.79 1.89%
Monthly
-9.01%
Yearly
38.07%
Q1 Forecast
615.95

Idexx Laboratories reported $774.97M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Abbott USD 9.21B 17M Dec/2025
Accuray USD 37.18M 567K Dec/2024
Align Technology USD 822.85M 11.8M Dec/2025
AngioDynamics USD 81.98M 1.96M Feb/2025
Dentsply International USD 1.48B 653M Sep/2025
Dexcom USD 936.6M 30.2M Dec/2025
Edwards Lifesciences USD 1.2B 71.3M Dec/2025
Fujifilm JPY 767.39B 27.7B Dec/2025
Globus Medical USD 886.57M 730.06M Sep/2025
Henry Schein USD 3.25B 110M Dec/2025
Hologic USD 349.4M 447.1M Dec/2025
Idexx Laboratories USD 774.97M 24.58M Dec/2025
Inogen USD 49.14M 665K Sep/2024
Insulet USD 637.5M 48.9M Dec/2025
Integra LifeSciences USD 1.04B 620.66M Sep/2025
Intuitive Surgical USD 2B 263.6M Dec/2025
Masimo USD 147M 159.4M Sep/2025
Neogen USD 230.07M 4.79M Sep/2025
Orthofix International USD 10.89M 209.57M Sep/2024
Phibro Animal Health USD 332.36M 20.68M Dec/2025
ResMed USD 925.21M 51.98M Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Steris USD 1.22B 28.8M Dec/2025
Tandem Diabetes Care USD 282.09M 9.97M Dec/2025
Teleflex USD 3.82B 3.22B Sep/2025
Thermo Fisher Scientific USD 9.91B 867M Dec/2025
Zoetis USD 1.55B 3.85B Dec/2025